When semaglutide was first approved for weight management, you needed a body mass index (BMI) of 30 or higher, or a documented medical condition
As obesity treatment becomes increasingly personalized, clinicians are often choosing among several highly effective therapies rather than deciding whether to treat at all, said co-author Yuan Lu, Assistant Professor of Cardiology at Penn Considering blood pressure, cholesterol, and glucose control together could be key to aligning with each patients overall, individualized cardiometabolic profile. Three focal points for the future Chen identified a collection of priorities for the next phase of GLP-1 research and obesity care
They slow down muscle recovery and may lead to sarcopenia
Marketed under the brand name 'Clearblue', this device not only made the process of pregnancy testing much easier and faster but also provided a template for the development of other self-testing diagnostics using immunoassays
Your routine does the work